Filing Flows › Haemonetics (HAE) › Gross margin
Haemonetics (HAE) gross margin by quarter
Haemonetics' gross margin was 61.7% in Q2 FY27 (second quarter fiscal 2027), +2.0 pts from Q1 FY27. Over the last 6 quarters it ranged from 58.4% (Q4 FY25) to 61.7% (Q2 FY27).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | 61.7% | +2.0 pts | +2.3 pts |
| Q1 FY27 | 59.8% | +0.1 pts | -0.1 pts |
| Q3 FY26 | 59.7% | +0.2 pts | — |
| Q2 FY26 | 59.5% | -0.3 pts | — |
| Q1 FY26 | 59.8% | +1.4 pts | — |
| Q4 FY25 | 58.4% | — | — |
Q2 FY27 at a glance
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
Questions
What is Haemonetics' gross margin?
Haemonetics' gross margin was 61.7% in Q2 FY27 (second quarter fiscal 2027), +2.0 pts from Q1 FY27.
How has Haemonetics' gross margin changed?
Over the last 6 quarters it ranged from 58.4% (Q4 FY25) to 61.7% (Q2 FY27).